The Ghana Health Service (GHS) is on high alert for acute respiratory infections particularly those caused by the Human Metapneumovirus (hMPV) to contain a possible outbreak in the country.
So far, the service says, surveillance across all 16 regions “have not shown any unusual respiratory pathogens including hMPV” in the country.
This comes on the back of reports of spread of the virus across China and other parts of the Northern Hemisphere since December 2024 raising fears of another likely global pandemic.
A statement issued and signed in Accra on Friday by the Director-General, Dr Patrick Kuma-Aboagye, explained that the virus was not a new one unlike COVID-19 and usual in winter periods, as is the case currently.
Nonetheless, he said the GHS was holding itself in readiness to safeguard the populace against risk of infection.
“The GHS in collaboration with other agencies and its partners is implementing various measures to ensure that it is well-positioned to detect early and respond to any surge in respiratory pathogens in line with WHO recommendations,” the statement assured.
The Service outlined measures being initiated including enhanced surveillance of acute respiratory infections, expanded laboratory testing, continuous assessment of developments in the Northern Hemisphere and increased public education campaigns to raise awareness against the virus.
It thus advised the public to adhere to practical preventive measures, such as practising proper respiratory hygiene, maintaining hand hygiene, avoiding touching the face, wearing face masks when necessary, seeking prompt medical care and adopting healthy dietary habits including eating fruits and vegetables.
“The GHS assures the public that it is taking necessary steps to protect the health of Ghanaians and will provide regular updates on the situation,” the statement noted.
Human Metapneumovirus (hMPV) is one of the viruses that causes common cold (upper respiratory infection), and its symptoms can range from mild to severe.
The infection can affect all individuals and is usually spread through inhalation of respiratory particles.
The common symptoms include cough, fever, sore throat, runny or stuffy nose, body ache and headache. Severe symptoms may include severe cough, difficulty in breathing, noisy breathing, persistent fever, chest pain, tiredness and dehydration.
Those at risk of developing severe illness include persons with underlying conditions like Asthma, chronic obstructive pulmonary disease, immunosuppressed persons, and the aged (above 65 years).
Treatment is usually supportive as the infection is self-limiting, however, practising good respiratory etiquette (covering the mouth and nose when coughing or sneezing), proper hand hygiene, avoid touching eyes, mouth and nose, wearing facemask when necessary and early reporting to health facilities when symptoms develop could avert severe impact.
BY ABIGAIL ANNOH
